OTT Oxford Technology 3 VCT PLC

Portfolio Update

Portfolio Update

The Board notes that on 3 June 2021 Arecor Therapeutics plc ("Arecor"), one of Oxford Technology 3 VCT Plc’s (“OT3”) investee companies, floated on AIM raising £20m via a placing at 226p per Arecor share. The flotation was a success and the Arecor bid price at close had risen to 238p per Arecor share.

The most recently published unaudited net asset value (NAV) for OT3 at 30 November 2020 was 38.4p per share. 

Compared to this last published OT3 NAV, the impact of the Arecor flotation in isolation is an increase in the OT3 NAV of £371k, or 5.5p per OT3 share.

Further detail – including an updated OT3 NAV as at 28 February 2021 and 31 May 2021 – will be available in the annual report which is expected to be released towards the end of this month. 

For further information contact:

Oxford Technology Management

Lucius Cary

01865 784466







EN
07/06/2021

Underlying

OTTOxford Technology 3 VCT PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Oxford Technology 3 VCT PLC

 PRESS RELEASE
Free
OTT Oxford Technolo...

Result of Meeting and Merger Update

Result of Meeting and Merger Update Oxford Technology 3 VCT PLC Results of General Meeting and Merger Update 30 June 2022 The Board of Oxford Technology 3 VCT plc ("the Company or “OT3") is pleased to announce the resolution to approve the Company being placed in liquidation, appoint the liquidators and cancel the listing of the Company's shares, was duly passed on a show of hands and with 97.4% of proxy votes received being in favour (or at the chairman's discretion). Full details are shown below. The general meeting of the Company held today was in connection with the me...

June 30, 2022 1 EN
 PRESS RELEASE
Free
OTT Oxford Technolo...

Temporary Suspension

Temporary Suspension Oxford Technology 3 VCT PLC (the “Company”) Statement re Suspension 30 June 2022 Prior to a resolution to effect the commencement of the winding up of the Company (and consequently both the cancellation of the listing of the Company's shares on the Official List of the Financial Conduct Authority and trading on the main market of the London Stock Exchange) that will be put to the Company's shareholders at today’s general meeting of the Company, trading in the Company's ordinary shares (ISIN: GB0031420390) has now been suspended at the request of the Compan...

June 30, 2022 1 EN
 PRESS RELEASE
Free
OTT Oxford Technolo...

Result of Meeting

Result of Meeting The Board of Oxford Technology 3 VCT Plc (OT3) is pleased to announce that the resolution to approve the OT3 Scheme proposed at the First General Meeting held today, 20 June 2022, was duly passed on a show of hands.  The Board of OT3 notes that the shareholders of each of Oxford Technology VCT Plc (OT1) and Oxford Technology 4 VCT Plc (OT4) have also approved the resolutions to enable the merger of their companies with OT2, and shareholders of OT2 have now passed all the resolutions to enable the issue of Consideration Shares and Leisure Shares, as set out in the Circul...

June 20, 2022 1 EN
 PRESS RELEASE
Free
OTT Oxford Technolo...

Publication of Prospectus

Publication of Prospectus JOINT ANNOUNCEMENT  18 MAY 2022  OXFORD TECHNOLOGY 2 VCT PLC ("OT2" or “COMPANY”)  LEI: 2138002COY2EXJDHWB30 OXFORD TECHNOLOGY VCT PLC ("OT1")     LEI: 213800HI61VDMTDOAX43 OXFORD TECHNOLOGY 3 VCT PLC ("OT3")  LEI: 2138008W5QZKMHHWRY76 OXFORD TECHNOLOGY 4 VCT PLC ("OT4")  LEI: 213800O9M2EQZD452H80 (TOGETHER, THE "COMPANIES" AND OT1, OT3 AND OT4 TOGETHER THE "TARGET VCTS" AND EACH A "TARGET VCT")  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL....

May 18, 2022 1 EN
 PRESS RELEASE
Free
OTT Oxford Technolo...

Net Asset Value(s)

Net Asset Value(s) Oxford Technology 3 VCT Plc – NAV Update  Oxford Technology 3 VCT Plc (“Company”, “OT3”) announces an update to its unaudited Net Asset Value per share (“NAV”) from the most recently published NAV (as at 19 April 2022), based on movements in its AIM quoted investments and an estimate of running costs. No other changes were required to the valuations of the Company’s unquoted investments.  As at 17 May 2022, the NAV per share has fallen by 10% from 46.8p to 42.2p.  The share prices of both quoted stocks have fallen - Arecor Therapeutics Plc (“Arecor” (390p to 370p...

May 17, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch